It also assessed 106,454 type 2 diabetes patients who were exposed to once-weekly semaglutide
Patients considering either option should discuss: Long-term expectations Cost considerations Side-effect management Nutrition support Physical activity plans Ongoing monitoring GLP-1 medications work best as part of a broader metabolic health strategy rather than as isolated quick fixes
Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial
Don's wait, book now and get your initial consult started
Portillo Canales presented her research on July 14 at ENDO 2025, the Endocrine Societys annual meeting in San Francisco, California
Patents exist to help pharmaceutical companies recoup research and development costs, but generics put pressure on healthcare systems to determine who should have access, how the drugs are priced and what role government coverage should play